Attorneys Demand Release of NAS Names Amid Purdue Bankruptcy
Attorneys get neonatal abstinence syndrome names to file claims against Purdue.
Drugs & Medical Devices
Meritus Cut Opioid Prescriptions without Patient Complaints
Health care provider, Meritus, was able to significantly reduce the number of opioids being prescribed.
Why Zantac Has Been Removed from the Market
The manufacturers of these medications have the responsibility of ensuring the public that their product is safe and effective, prolonging their chance of living without getting any risk to their health and safety.
Those Affected by Purdue’s OxyContin Want the Truth
Victims on Purdue Pharma’s deceptive marketing practices want justice.
Data Shows Non-opioid Alternatives are on the Rise
The market for non-opioid pain treatment options is increasing, according to recent data.
COVID-19 Patients, Hospital Staff Burdened by DEA Quotas
Coronavirus patients on ventilators are feeling the pinch of federal drug quotas.
Indivior Offers $600 Million to Settle Justice Department Investigation
Suboxone film drugmaker settles federal probe finding it misrepresented the drug’s benefits.
FDA Will Now Require Naloxone Info on Opioid Labels
The Food and Drug Administration requires Narcan information to be present on the labels of prescription opioids.
Opioid Task Force Requests Barrier Removal for Addiction Treatment
The American Medical Association Opioid Task Force believes barriers need to be removed for evidence-based treatments.
Experts Suggest Sacklers Could Get Their Bankruptcy Settlement
Legal experts suggest the Sacklers may just get their way after all.